...
首页> 外文期刊>Breast cancer research and treatment. >Breast-conserving therapy after previous irradiation for lymphoma.
【24h】

Breast-conserving therapy after previous irradiation for lymphoma.

机译:以前照射淋巴瘤后的哺乳治疗。

获取原文
获取原文并翻译 | 示例

摘要

There is an increased risk of breast cancer in patients who have undergone radiation treatment for lymphoma. While this usually precludes further radiotherapy (RT), we report five women who received irradiation for lymphoma and who subsequently received breast-conserving therapy between 1995 and 2007 for early-stage breast cancer. There was an overlap between the two treatment fields in all patients. RT for lymphoma ranged between 29.8 and 40 grays (Gy). The interval between lymphoma and the diagnosis of breast cancer was 11-24 years. All five patients had lumpectomy and received subsequent RT (45 Gy in four patients, 50 Gy in the other). All tolerated breast RT well, and toxicity was limited to grade 1 events. All five patients were alive at last follow-up, and there was no local recurrence in the irradiated breast in any patient. We conclude that previous RT for lymphoma is not necessarily an absolute contraindication to breast-conserving therapy.
机译:对淋巴瘤进行辐射治疗的患者患乳腺癌的风险增加。 虽然这通常会排除进一步放射治疗(RT),但我们报告了五名接受淋巴瘤辐射的妇女,并随后在1995年至2007年期间接受了早期乳腺癌的哺乳治疗。 所有患者的两个治疗领域之间存在重叠。 淋巴瘤的RT间距在29.8和40灰(GY)之间。 淋巴瘤之间的间隔和乳腺癌的诊断为11-24岁。 所有五名患者都有乳肌切除术并接受后续RT(4例患者45岁,另有50次)。 所有耐受性乳房RT孔,毒性都限于1级事件。 所有五名患者在最后一次随访中都活着,并且在任何患者的辐照乳房中都没有局部复发。 我们得出结论,以前的RT用于淋巴瘤不一定是对哺乳治疗的绝对禁忌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号